|
Evan Levine has served as a Director of QuantRx since September, 2005, but has informed QuantRx of his intention not to stand for re-election to the Board; therefore, his term will expire at the 2007 Annual Meeting of Stockholders. Mr. Levine is currently Vice Chairman, President and Chief Executive Officer of
ADVENTRX Pharmaceuticals, Inc. a publicly traded biotechnology company. Mr. Levine is also the Managing Member of Mark Capital, LLC, a Venture Capital Fund. Mr. Levine has over 18 years of investment banking, venture capital, arbitrage and senior corporate management experience. Mr. Levine is a Class 1 Director
whose term expires in 2007. | 